Invention Grant
- Patent Title: Compounds useful as kinase inhibitors
-
Application No.: US16109162Application Date: 2018-08-22
-
Publication No.: US10342780B2Publication Date: 2019-07-09
- Inventor: Nicolas Guisot
- Applicant: Loxo Oncology, Inc.
- Applicant Address: US CT Stamford
- Assignee: Loxo Oncology, Inc.
- Current Assignee: Loxo Oncology, Inc.
- Current Assignee Address: US CT Stamford
- Agency: Fish & Richardson P.C.
- Priority: GB1522245.8 20151216; GB1613945.3 20160815
- Main IPC: C07D405/06
- IPC: C07D405/06 ; C07D231/38 ; A61K31/415 ; C07D405/14 ; C07D231/14 ; C07D401/04 ; C07D401/06 ; C07D403/04 ; C07D405/04 ; C07D405/08 ; C07D413/06 ; A61K45/06 ; A61P35/00 ; A61K31/4155 ; A61P37/02 ; A61P35/02
Abstract:
This invention relates to novel compounds. The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine kinase (BTK). The invention also contemplates the use of the compounds for treating conditions treatable by the inhibition of Bruton's tyrosine kinase, for example cancer, lymphoma, leukemia and immunological diseases.
Public/Granted literature
- US20180362512A1 COMPOUNDS USEFUL AS KINASE INHIBITORS Public/Granted day:2018-12-20
Information query
